258 related articles for article (PubMed ID: 30052659)
1. The extracellular matrix proteoglycan fibromodulin is upregulated in clinical and experimental heart failure and affects cardiac remodeling.
Andenæs K; Lunde IG; Mohammadzadeh N; Dahl CP; Aronsen JM; Strand ME; Palmero S; Sjaastad I; Christensen G; Engebretsen KVT; Tønnessen T
PLoS One; 2018; 13(7):e0201422. PubMed ID: 30052659
[TBL] [Abstract][Full Text] [Related]
2. Moderate Loss of the Extracellular Matrix Proteoglycan Lumican Attenuates Cardiac Fibrosis in Mice Subjected to Pressure Overload.
Mohammadzadeh N; Melleby AO; Palmero S; Sjaastad I; Chakravarti S; Engebretsen KVT; Christensen G; Lunde IG; Tønnessen T
Cardiology; 2020; 145(3):187-198. PubMed ID: 31968347
[TBL] [Abstract][Full Text] [Related]
3. Innate immune signaling induces expression and shedding of the heparan sulfate proteoglycan syndecan-4 in cardiac fibroblasts and myocytes, affecting inflammation in the pressure-overloaded heart.
Strand ME; Herum KM; Rana ZA; Skrbic B; Askevold ET; Dahl CP; Vistnes M; Hasic A; Kvaløy H; Sjaastad I; Carlson CR; Tønnessen T; Gullestad L; Christensen G; Lunde IG
FEBS J; 2013 May; 280(10):2228-47. PubMed ID: 23374111
[TBL] [Abstract][Full Text] [Related]
4. The extracellular matrix proteoglycan lumican improves survival and counteracts cardiac dilatation and failure in mice subjected to pressure overload.
Mohammadzadeh N; Lunde IG; Andenæs K; Strand ME; Aronsen JM; Skrbic B; Marstein HS; Bandlien C; Nygård S; Gorham J; Sjaastad I; Chakravarti S; Christensen G; Engebretsen KVT; Tønnessen T
Sci Rep; 2019 Jun; 9(1):9206. PubMed ID: 31235849
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
Alex L; Russo I; Holoborodko V; Frangogiannis NG
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic inhibition of the enzymatic effects of tissue transglutaminase reduces cardiac fibrosis and attenuates cardiomyocyte hypertrophy following pressure overload.
Shinde AV; Su Y; Palanski BA; Fujikura K; Garcia MJ; Frangogiannis NG
J Mol Cell Cardiol; 2018 Apr; 117():36-48. PubMed ID: 29481819
[TBL] [Abstract][Full Text] [Related]
7. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
[TBL] [Abstract][Full Text] [Related]
8. Syndecan-4 is a key determinant of collagen cross-linking and passive myocardial stiffness in the pressure-overloaded heart.
Herum KM; Lunde IG; Skrbic B; Louch WE; Hasic A; Boye S; Unger A; Brorson SH; Sjaastad I; Tønnessen T; Linke WA; Gomez MF; Christensen G
Cardiovasc Res; 2015 May; 106(2):217-26. PubMed ID: 25587045
[TBL] [Abstract][Full Text] [Related]
9. Lumican is increased in experimental and clinical heart failure, and its production by cardiac fibroblasts is induced by mechanical and proinflammatory stimuli.
Engebretsen KV; Lunde IG; Strand ME; Waehre A; Sjaastad I; Marstein HS; Skrbic B; Dahl CP; Askevold ET; Christensen G; Bjørnstad JL; Tønnessen T
FEBS J; 2013 May; 280(10):2382-98. PubMed ID: 23480731
[TBL] [Abstract][Full Text] [Related]
10. Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
Suzuki K; Satoh K; Ikeda S; Sunamura S; Otsuki T; Satoh T; Kikuchi N; Omura J; Kurosawa R; Nogi M; Numano K; Sugimura K; Aoki T; Tatebe S; Miyata S; Mukherjee R; Spinale FG; Kadomatsu K; Shimokawa H
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):636-46. PubMed ID: 26916734
[TBL] [Abstract][Full Text] [Related]
11. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
[TBL] [Abstract][Full Text] [Related]
12. Osteoglycin prevents cardiac dilatation and dysfunction after myocardial infarction through infarct collagen strengthening.
Van Aelst LN; Voss S; Carai P; Van Leeuwen R; Vanhoutte D; Sanders-van Wijk S; Eurlings L; Swinnen M; Verheyen FK; Verbeken E; Nef H; Troidl C; Cook SA; Brunner-La Rocca HP; Möllmann H; Papageorgiou AP; Heymans S
Circ Res; 2015 Jan; 116(3):425-36. PubMed ID: 25520363
[TBL] [Abstract][Full Text] [Related]
13. Partial inhibition of activin receptor-like kinase 4 attenuates pressure overload-induced cardiac fibrosis and improves cardiac function.
Li CY; Chen YH; Wang Q; Hou JW; Wang H; Wang YP; Li YG
J Hypertens; 2016 Sep; 34(9):1766-77. PubMed ID: 27379535
[TBL] [Abstract][Full Text] [Related]
14. Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling.
Dahl CP; Husberg C; Gullestad L; Waehre A; Damås JK; Vinge LE; Finsen AV; Ueland T; Florholmen G; Aakhus S; Halvorsen B; Aukrust P; Oie E; Yndestad A; Christensen G
Circ Heart Fail; 2009 Nov; 2(6):624-32. PubMed ID: 19919988
[TBL] [Abstract][Full Text] [Related]
15. Syndecan-4 deficiency accelerates the transition from compensated hypertrophy to heart failure following pressure overload.
Li G; Xie J; Chen J; Li R; Wu H; Zhang X; Chen Q; Gu R; Xu B
Cardiovasc Pathol; 2017; 28():74-79. PubMed ID: 28395201
[TBL] [Abstract][Full Text] [Related]
16. miR-146a Suppresses SUMO1 Expression and Induces Cardiac Dysfunction in Maladaptive Hypertrophy.
Oh JG; Watanabe S; Lee A; Gorski PA; Lee P; Jeong D; Liang L; Liang Y; Baccarini A; Sahoo S; Brown BD; Hajjar RJ; Kho C
Circ Res; 2018 Aug; 123(6):673-685. PubMed ID: 30355233
[TBL] [Abstract][Full Text] [Related]
17. Tissue transglutaminase induction in the pressure-overloaded myocardium regulates matrix remodelling.
Shinde AV; Dobaczewski M; de Haan JJ; Saxena A; Lee KK; Xia Y; Chen W; Su Y; Hanif W; Kaur Madahar I; Paulino VM; Melino G; Frangogiannis NG
Cardiovasc Res; 2017 Jul; 113(8):892-905. PubMed ID: 28371893
[TBL] [Abstract][Full Text] [Related]
18. Neuron-derived orphan receptor-1 modulates cardiac gene expression and exacerbates angiotensin II-induced cardiac hypertrophy.
Cañes L; Martí-Pàmies I; Ballester-Servera C; Herraiz-Martínez A; Alonso J; Galán M; Nistal JF; Muniesa P; Osada J; Hove-Madsen L; Rodríguez C; Martínez-González J
Clin Sci (Lond); 2020 Feb; 134(3):359-377. PubMed ID: 31985010
[TBL] [Abstract][Full Text] [Related]
19. Deletion of Microfibrillar-Associated Protein 4 Attenuates Left Ventricular Remodeling and Dysfunction in Heart Failure.
Wang HB; Yang J; Shuai W; Yang J; Liu LB; Xu M; Tang QZ
J Am Heart Assoc; 2020 Sep; 9(17):e015307. PubMed ID: 32856514
[TBL] [Abstract][Full Text] [Related]
20. The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.
Kritzer MD; Li J; Passariello CL; Gayanilo M; Thakur H; Dayan J; Dodge-Kafka K; Kapiloff MS
Circ Heart Fail; 2014 Jul; 7(4):663-72. PubMed ID: 24812305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
